Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01384045 · ClinicalTrials.gov registry record · NA
Outreach for Diabetes Cure
A NA study of Type II Diabetes, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 2,800
- Enrollment target
- 1
- Study location
NCT01384045: Completed NA study of Type II Diabetes, sponsored by University of Colorado, Denver.
NCT01384045 is a NA study of Type II Diabetes that has completed, run by University of Colorado, Denver. The registered enrollment target is 2,800 participants, above the 215-participant average among 6 other Type II Diabetes trials with a reported enrollment target (1202% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01384045, a NA study of Type II Diabetes, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,800 participants
- Enrollment target
- 1
- Study location
Study Summary
Using a socioeconomic, race/ethnic, and gender-diverse sample of patients who receive diabetes care from a University of Colorado Hospital (UCH) primary care provider (PCP), carry out a randomized-controlled trial of usual care versus an outreach intervention designed to increase guideline concordance with American Diabetes Association (ADA) recommendations for blood pressure, Low-density lipoprotein (LDL), and glycosylated hemoglobin (A1c) goals, referrals for retinal exams, and aspirin therapy.Primary hypotheses: The proportion of patients meeting goal will be 10% higher in the intervention compared with control group in the following domains: 1. LDL\<100 mg/dL; 2. A1c\<7.0%; and 3. Systolic blood pressure\<130 mm Hg or diastolic blood pressure\<80 mm Hg.
Primary Outcome
Composite measure of guideline concordance with 1 point for concordance with each of the following: 1. hemoglobin a1c less than 7% 2. ldl cholesterol less than 100 mgs per decaliter 3. urinary micro albumin measured in preceding 12 months 4. both systolic bp less than 130 mms mercury \& diastolic bp less than 80 mms mercury
Conditions Studied
Interventions
- OTHER Health promotion outreach
Study Locations (1)
Colorado
- University of Colorado Hopspital - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,800 participants |
| Start Date | 2009-02 |
| Est. Completion | 2011-06 |
| Phase | NA |
What the finished NCT01384045 record still lists
NCT01384045 is an interventional study that assigns participants to a tested intervention. Its 2,800 participants enrollment target places it among the larger protocols in the corpus, above the 215-participant average among 6 other Type II Diabetes trials with a reported enrollment target (1202% higher).
The record links to 1 condition, with Type II Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Health promotion outreach is the first listed.
NCT01384045 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT01384045 about?
NCT01384045 is a clinical study titled "Outreach for Diabetes Cure". Using a socioeconomic, race/ethnic, and gender-diverse sample of patients who receive diabetes care from a University of Colorado Hospital (UCH) primary care provider (PCP), carry out a randomized-controlled trial of usual care versus an outreach intervention designed to increase guideline concordan...
What is the current status of trial NCT01384045?
This trial is currently completed. It is a NA study. The enrollment target is 2,800 participants. The study started on 2009-02. Estimated completion is 2011-06.
What conditions does trial NCT01384045 study?
This clinical trial studies the following conditions: Type II Diabetes.
What interventions are being tested in trial NCT01384045?
The interventions under investigation include: Health promotion outreach (OTHER).
Who is sponsoring clinical trial NCT01384045?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01384045 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type II Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The GRoceries Aimed at Increasing Nutrition Study
RECRUITING · NA
-
Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients
RECRUITING · NA
-
Biospecimens for Identification of Diseases of the Pancreas.
COMPLETED · NA
-
Dietary Approaches to Stop Hypertension for Diabetes
COMPLETED · NA
-
Evaluation of a Prototype Diabetes Management System Applied to Insulin Initiation and Titration
COMPLETED · NA
-
Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05443737 · 2,800 participants · Phase 3
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
- NCT05899439 · 2,800 participants
Immune Function and the Progression to T1D
- NCT06089109 · 2,800 participants · NA
Creating VIP Corps to Reduce Maternal Deaths
- NCT06345339 · 2,800 participants · Phase 2
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia